News and Trends 7 Nov 2018
Belgian Biotech to Abandon Phase III Cell Therapy Trial for Bone Disease
Bone Therapeutics is going to discontinue its cell therapy Phase III trial after finding little hope of success for patients with the bone disease osteonecrosis. If all had gone as…